{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:58:09Z","timestamp":1785164289414,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1124\/jpet.114.214437","type":"journal-article","created":{"date-parts":[[2014,6,20]],"date-time":"2014-06-20T02:20:16Z","timestamp":1403230816000},"page":"495-505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders"],"prefix":"10.1016","volume":"350","author":[{"given":"Mikhail","family":"Kalinichev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Le Poul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Bol\u00e9a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brice","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Fonsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Royer-Urios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Browne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Uslaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Raber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Duvoisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon T.","family":"Bate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian J.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Celanire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.114.214437_bib1","series-title":"The Design and Statistical Analysis of Animal Experiments","author":"Bate","year":"2014"},{"key":"10.1124\/jpet.114.214437_bib2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3109\/01677063.2011.627485","article-title":"Characterization of an mGluR2\/3 negative allosteric modulator in rodent models of depression","volume":"25","author":"Campo","year":"2011","journal-title":"J Neurogenet"},{"key":"10.1124\/jpet.114.214437_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1517\/17460441.2012.660914","article-title":"Recent advances in the drug discovery of metabotropic glutamate receptor 4 (mGluR4) activators for the treatment of CNS and non-CNS disorders","volume":"7","author":"C\u00e9lanire","year":"2012","journal-title":"Expert Opin Drug Discov"},{"key":"10.1124\/jpet.114.214437_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tips.2008.10.006","article-title":"Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia","volume":"30","author":"Conn","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.114.214437_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0306-4522(01)00591-7","article-title":"Distribution and synaptic localisation of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS","volume":"110","author":"Corti","year":"2002","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.114.214437_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbr.2011.12.037","article-title":"Measures of anxiety, sensorimotor function, and memory in male and female mGluR4\u207b\/\u207b mice","volume":"229","author":"Davis","year":"2012","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.114.214437_bib7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.neuropharm.2012.07.038","article-title":"Role of mGluR4 in acquisition of fear learning and memory","volume":"66","author":"Davis","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.114.214437_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1476-5381.2010.00882.x","article-title":"Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson\u2019s disease","volume":"161","author":"Duty","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.114.214437_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbr.2011.02.049","article-title":"Opposing roles of mGluR8 in measures of anxiety involving non-social and social challenges","volume":"221","author":"Duvoisin","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.114.214437_bib10","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.1073\/pnas.1034823100","article-title":"Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression","volume":"100","author":"El Yacoubi","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.114.214437_bib11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3758\/BF03210947","article-title":"Neural organization of the defensive behavior system responsible for fear","volume":"1","author":"Fanselow","year":"1994","journal-title":"Psychon Bull Rev"},{"key":"10.1124\/jpet.114.214437_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.biopsych.2013.08.014","article-title":"A mouse model that recapitulates cardinal features of the 15q13.3 microdeletion syndrome including schizophrenia- and epilepsy-related alterations","volume":"76","author":"Fejgin","year":"2014","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.114.214437_bib13","unstructured":"Festing MFW, Overend P, Gaines RD, Borja MC, and Berdoy M (2002) The Design of Animal Experiments: Reducing the Use of Animals in Research Through Better Experimental Design, Ed. 1st. The Royal Society of Medicine Press Limited, London."},{"key":"10.1124\/jpet.114.214437_bib14","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/sj.npp.1300625","article-title":"Cognitive deficits caused by late gestational disruption of neurogenesis in rats: a preclinical model of schizophrenia","volume":"30","author":"Flagstad","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.114.214437_bib15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1469-8986.1997.tb02389.x","article-title":"Fear-potentiated startle conditioning in humans: explicit and contextual cue conditioning following paired versus unpaired training","volume":"34","author":"Grillon","year":"1997","journal-title":"Psychophysiology"},{"key":"10.1124\/jpet.114.214437_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1124\/jpet.111.186577","article-title":"GABAB receptor-positive modulators: brain region-dependent effects","volume":"340","author":"Hensler","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.114.214437_bib17","first-page":"4","article-title":"Glutamatergic theories of schizophrenia","volume":"47","author":"Javitt","year":"2010","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"10.1124\/jpet.114.214437_bib18","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1124\/jpet.114.214437_bib19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1124\/jpet.112.200915","article-title":"ADX71743, a potent and selective negative allosteric modulator of metabotropic glutamate receptor 7: in vitro and in vivo characterization","volume":"344","author":"Kalinichev","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.114.214437_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1517\/14728222.9.1.153","article-title":"GABA and glutamate systems as therapeutic targets in depression and mood disorders","volume":"9","author":"Kendell","year":"2005","journal-title":"Expert Opin Ther Targets"},{"key":"10.1124\/jpet.114.214437_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1124\/jpet.112.196063","article-title":"A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson\u2019s disease","volume":"343","author":"Le Poul","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.114.214437_bib22","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1124\/jpet.108.136580","article-title":"ADX47273 [S-(4-fluoro-phenyl)-3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities","volume":"327","author":"Liu","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.114.214437_bib23","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.neuropharm.2011.12.019","article-title":"Long lasting effects of early-life stress on glutamatergic\/GABAergic circuitry in the rat hippocampus","volume":"62","author":"Martisova","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.114.214437_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2006.07.015","article-title":"A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants","volume":"547","author":"Nicolas","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.114.214437_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1124\/pr.111.005397","article-title":"The flinders sensitive line rat model of depression\u201425 years and still producing","volume":"65","author":"Overstreet","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.114.214437_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuropharm.2003.09.006","article-title":"Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats","volume":"46","author":"Pa\u0142ucha","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.114.214437_bib27","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.neuropharm.2008.06.033","article-title":"Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents","volume":"55","author":"Pa\u0142ucha-Poniewiera","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.114.214437_bib28","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1523\/JNEUROSCI.16-20-06364.1996","article-title":"Impaired cerebellar synaptic plasticity and motor performance in mice lacking the mGluR4 subtype of metabotropic glutamate receptor","volume":"16","author":"Pekhletski","year":"1996","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.114.214437_bib29","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.biopsych.2013.01.021","article-title":"Glutamate-based antidepressants: preclinical psychopharmacology","volume":"73","author":"Pilc","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.114.214437_bib30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/appi.ajp.160.3.577","article-title":"Increased cortical GABA concentrations in depressed patients receiving ECT","volume":"160","author":"Sanacora","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1124\/jpet.114.214437_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neuropharm.2012.05.001","article-title":"Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu\u2084 receptor","volume":"66","author":"S\u0142awi\u0144ska","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.114.214437_bib31","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1111\/bph.12254","article-title":"The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents","volume":"169","author":"S\u0142awi\u0144ska","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.114.214437_bib33","first-page":"820","article-title":"Anxiolytic-like effects of group III mGlu receptor ligands in the hippocampus involve GABAA signaling","volume":"58","author":"Stachowicz","year":"2006","journal-title":"Pharmacol Rep"},{"key":"10.1124\/jpet.114.214437_bib34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejphar.2004.07.001","article-title":"Anxiolytic-like effects of PHCCC, an allosteric modulator of mGlu4 receptors, in rats","volume":"498","author":"Stachowicz","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.114.214437_bib35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuropharm.2009.06.005","article-title":"The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems","volume":"57","author":"Stachowicz","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.114.214437_bib36","first-page":"707","article-title":"Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats","volume":"54","author":"Tatarczy\u0144ska","year":"2002","journal-title":"Pol J Pharmacol"},{"key":"10.1124\/jpet.114.214437_bib37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00213-009-1466-y","article-title":"Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety","volume":"204","author":"Thomas","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.114.214437_bib38","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00213-013-3005-0","article-title":"The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT\u2081A signalling","volume":"227","author":"Wiero\u0144ska","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.114.214437_bib39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00213-011-2502-2","article-title":"Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia","volume":"220","author":"Wiero\u0144ska","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.114.214437_bib40","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuropharm.2010.08.008","article-title":"Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems","volume":"59","author":"Wiero\u0144ska","year":"2010","journal-title":"Neuropharmacology"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524187769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524187769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.114.214437","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:46:02Z","timestamp":1739987162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524187769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0022356524187769"],"URL":"https:\/\/doi.org\/10.1124\/jpet.114.214437","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.114.214437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}